Issues
-
Cover Image
Cover Image
Obesity and poor diet are modifiable risk factors for breast cancer. In the study starting on page 415, Arnone and colleagues investigated the impact of key nutritional factors by modifying fat source (lard, coconut oil, safflower oil, or flaxseed oil) or dietary sugar content on the gut microbiome, mammary gland inflammation, and carcinogen-induced mammary carcinogenesis risk in preclinical murine models. The cover image is adapted from Fig. 3D, showing consumption of a high-fat lard-based diet increased M1-like macrophages within the mammary gland tissue, which was not observed in animals consuming a high-fat lard + flaxseed oil diet. These data suggest that the addition of n-3 PUFA into a high-fat diet reduces mammary gland inflammation and potentially attenuates tumor formation. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Highlights from the Literature
Spotlight
Review
Research Articles
Diet Modulates the Gut Microbiome, Metabolism, and Mammary Gland Inflammation to Influence Breast Cancer Risk
Our study demonstrates the impact of diet on breast cancer risk, focusing on the interplay between diet, the gut microbiome, and mammary gland inflammation.
Effect of Clonal Hematopoiesis Mutations and Canakinumab Treatment on Incidence of Solid Tumors in the CANTOS Randomized Clinical Trial
We reveal that administering canakinumab is associated with a decrease in non-hematological malignancies among patients with clonal hematopoiesis (CH) mutations. These findings underscore canakinumab’s potential in preventing cancer and provide proof of IL1β blockade collaborating with CH mutations to enhance its clinical benefits.
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.